Cannabis/Marijuana for Healthcare 2022
DOI: 10.1007/978-981-16-8822-5_3
|View full text |Cite
|
Sign up to set email alerts
|

Cannabinoids in Cancer: Cross-talk Between Cannabinoids and miRNAs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 92 publications
0
1
0
Order By: Relevance
“…CBs have been found to have anticancer effects by triggering apoptosis and suppressing telomerase activity. Low molecular weight hemp peptides have been shown to induce apoptosis, decrease cell viability, and reduce cell motility in Hep3B human liver cancer cells without modifying the baseline overexpression of cleaved caspase 3 and Bad, or downregulation of antiapoptotic Bcl-2 ( Salamat et al, 2022 ). This strategy induced Akt and GSK-3 phosphorylation, followed by downregulation of β-catenin, demonstrating that β-catenin’s signaling modulation is the mechanism governing the anticancer activity.…”
Section: Pharmacological Potential Of Cannabismentioning
confidence: 99%
“…CBs have been found to have anticancer effects by triggering apoptosis and suppressing telomerase activity. Low molecular weight hemp peptides have been shown to induce apoptosis, decrease cell viability, and reduce cell motility in Hep3B human liver cancer cells without modifying the baseline overexpression of cleaved caspase 3 and Bad, or downregulation of antiapoptotic Bcl-2 ( Salamat et al, 2022 ). This strategy induced Akt and GSK-3 phosphorylation, followed by downregulation of β-catenin, demonstrating that β-catenin’s signaling modulation is the mechanism governing the anticancer activity.…”
Section: Pharmacological Potential Of Cannabismentioning
confidence: 99%